Wednesday, June 20, 2007

Five New Tongue Twisters From Glaxo
ScienceBlogs - USA
Last, but not least, is ofatumumab (reminds me of the hula dancer at Uncle Louie's luau), a fully human monoclonal antibody against the CD-20 antigen, ...
See all stories on this topic

Can goats' blood help beat MS? My mother is walking proof it can
Daily Mail - UK
When her mother, Diana, began taking an unlicensed experimental drug made from goats' blood for multiple sclerosis, you might imagine Jackie Llewellyn-Bowen ...
See all stories on this topic

Ahead of the Bell: Acorda Upgraded
Houston Chronicle - United States
The study is designed to test if Fampridine improves patients' ability to walk. Acorda said the trial started June 6, and Ho expects it to end within a year ...
See all stories on this topic

Genmab-GSK drug has arthritis potential
BiopharmaReporter.com - Montpellier,France
As such it is a direct competitor to Roche's MabThera/Rituxan (rituximab), which made sales of $3.9bn (EURO 2.9bn) in 2006. However, according to analysts, ...
See all stories on this topic

Short-term Treasury bills off
San Diego Union Tribune - United States
Tysabri is now sold under a restricted distribution system that allows Cambridge, Mass.-based Biogen-Idec, which has research facilities in San Diego, ...
See all stories on this topic

0 Comments:

Post a Comment

<< Home